• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群成员间串扰的多样化变化与冠状动脉疾病的发生发展。

Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.

机构信息

State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, School of Life Sciences, Yunnan Universitygrid.440773.3, Kunming, Yunnan, People's Republic of China.

Department of Cardiology, Key Laboratory of Cardiovascular Disease of Yunnan Province, Yan'an Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China.

出版信息

Microbiol Spectr. 2022 Dec 21;10(6):e0280422. doi: 10.1128/spectrum.02804-22. Epub 2022 Oct 27.

DOI:10.1128/spectrum.02804-22
PMID:36301099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9769841/
Abstract

Coronary artery disease (CAD) is one of leading causes of mortality worldwide. Studies on roles that the gut microbiota plays in development of atherosclerosis or acute myocardial infarction (AMI) have been widely reported. However, the gut microbiota is affected by many factors, including age, body mass index (BMI), and hypertension, that lead to high CAD risk. However, the associations between gut microbiota and CAD development or other CAD risk factors remain unexplored. Here, we performed a 16S RNA gene sequencing analysis of 306 fecal samples collected from patients with mild coronary stenosis (MCS;  = 36), stable angina (SA;  = 91), unstable angina (UA;  = 48), and acute myocardial infarction (AMI;  = 66) and 65 non-CAD controls. Using a noise-corrected method based on principal-component analysis (PCA) and the random forest algorithm, we identified the interference with gut microbial profiling of multiple factors (including age, gender, BMI, and hypertension) that potentially contributed significantly to the development of CAD. After correction of noise interference from certain interfering factors, we found consistent indicator microbiota organisms (such as , , and ) associated with the presence of MCS, SA, and AMI. Establishment of a diagnostic model revealed better performance in early CAD than clinical indexes with indicator microbes. Furthermore, indicator microbes can improve the accuracy of clinical indexes for the diagnosis of AMI. Additionally, we found that the microbial indicators of AMI and showed consistent positive and negative correlations to the clinical indexes creatine kinase (CK) and hemoglobin (Hb), respectively. As a control indicator of AMI, was negatively correlated with CK but positively correlated with Hb. Our study discovered the effect of confounding factors on gut microbial variations and identified gut microbial indicators possibly associated with the CAD development after noise correction. Our discovered indicator microbes may have potential for diagnosis or therapy of cardiovascular disorders.

摘要

冠状动脉疾病(CAD)是全球主要的死亡原因之一。关于肠道微生物群在动脉粥样硬化或急性心肌梗死(AMI)发展中的作用的研究已经广泛报道。然而,肠道微生物群受到许多因素的影响,包括年龄、体重指数(BMI)和高血压,这些因素导致 CAD 风险增加。然而,肠道微生物群与 CAD 发展或其他 CAD 危险因素之间的关联仍未得到探索。在这里,我们对 306 份粪便样本进行了 16S RNA 基因测序分析,这些样本来自轻度冠状动脉狭窄(MCS;=36)、稳定型心绞痛(SA;=91)、不稳定型心绞痛(UA;=48)和急性心肌梗死(AMI;=66)患者以及 65 名非 CAD 对照。使用基于主成分分析(PCA)和随机森林算法的噪声校正方法,我们确定了多种因素(包括年龄、性别、BMI 和高血压)对肠道微生物群谱的干扰,这些因素可能对 CAD 的发展有显著贡献。在对某些干扰因素的噪声干扰进行校正后,我们发现与 MCS、SA 和 AMI 存在一致的指示微生物群生物(如、和)。建立诊断模型显示,指示微生物在早期 CAD 中的性能优于临床指标。此外,指示微生物可以提高临床指标诊断 AMI 的准确性。此外,我们发现 AMI 的微生物指标和与临床指标肌酸激酶(CK)和血红蛋白(Hb)分别呈一致的正相关和负相关。作为 AMI 的控制指标,与 CK 呈负相关,与 Hb 呈正相关。我们的研究发现了混杂因素对肠道微生物变化的影响,并在噪声校正后确定了可能与 CAD 发展相关的肠道微生物指标。我们发现的指示微生物可能对心血管疾病的诊断或治疗具有潜在的应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/63cd4f788cdd/spectrum.02804-22-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/122ea222f409/spectrum.02804-22-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/2d4a2363b5df/spectrum.02804-22-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/3f924e953c83/spectrum.02804-22-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/5d1047a30436/spectrum.02804-22-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/30ffb9a04ba5/spectrum.02804-22-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/63cd4f788cdd/spectrum.02804-22-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/122ea222f409/spectrum.02804-22-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/2d4a2363b5df/spectrum.02804-22-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/3f924e953c83/spectrum.02804-22-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/5d1047a30436/spectrum.02804-22-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/30ffb9a04ba5/spectrum.02804-22-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/895e/9769841/63cd4f788cdd/spectrum.02804-22-f006.jpg

相似文献

1
Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.肠道微生物群成员间串扰的多样化变化与冠状动脉疾病的发生发展。
Microbiol Spectr. 2022 Dec 21;10(6):e0280422. doi: 10.1128/spectrum.02804-22. Epub 2022 Oct 27.
2
Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.肠道微生物群与代谢物相结合揭示了急性心肌梗死患者不同于稳定型冠状动脉疾病患者的独特特征。
J Adv Res. 2023 Apr;46:101-112. doi: 10.1016/j.jare.2022.06.008. Epub 2022 Jun 21.
3
Dysbiosis signatures of gut microbiota in coronary artery disease.肠道微生物失调特征与冠状动脉疾病。
Physiol Genomics. 2018 Oct 1;50(10):893-903. doi: 10.1152/physiolgenomics.00070.2018. Epub 2018 Sep 7.
4
C-reactive protein and coronary artery disease.C反应蛋白与冠状动脉疾病
Jpn Heart J. 2002 Nov;43(6):607-19. doi: 10.1536/jhj.43.607.
5
Alterations in gut microbiota and host transcriptome of patients with coronary artery disease.冠心病患者肠道微生物群和宿主转录组的改变。
BMC Microbiol. 2023 Nov 3;23(1):320. doi: 10.1186/s12866-023-03071-w.
6
API expert consensus document on management of ischemic heart disease.缺血性心脏病管理的API专家共识文件
J Assoc Physicians India. 2006 Jun;54:469-80.
7
The changes of gut microbiota after acute myocardial infarction in rats.大鼠急性心肌梗死后肠道微生物群的变化。
PLoS One. 2017 Jul 7;12(7):e0180717. doi: 10.1371/journal.pone.0180717. eCollection 2017.
8
Comprehensive Metabolomic Characterization of Coronary Artery Diseases.冠状动脉疾病的综合代谢组学特征。
J Am Coll Cardiol. 2016 Sep 20;68(12):1281-93. doi: 10.1016/j.jacc.2016.06.044.
9
Alterations in the gut mycobiome with coronary artery disease severity.肠道微生物组与冠状动脉疾病严重程度的改变。
EBioMedicine. 2024 May;103:105137. doi: 10.1016/j.ebiom.2024.105137. Epub 2024 May 3.
10
Serum neopterin and activity of coronary artery disease.血清新蝶呤与冠状动脉疾病的活性
Heart Dis. 2001 Sep-Oct;3(5):297-301. doi: 10.1097/00132580-200109000-00004.

引用本文的文献

1
Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases.运动预防心血管疾病的机制:从心血管疾病病理状态下的肠道微生物群特征中获得的见解
Rev Endocr Metab Disord. 2025 Jun 9. doi: 10.1007/s11154-025-09971-8.
2
The Critical Role of in Cardiovascular Diseases.(原文中“in Cardiovascular Diseases”前缺少具体内容,推测可能是某个因素之类的,这里仅按现有内容翻译)……在心血管疾病中的关键作用。
Rev Cardiovasc Med. 2025 Mar 20;26(3):26740. doi: 10.31083/RCM26740. eCollection 2025 Mar.
3
Causal relationships of gut microbiota and blood metabolites with ovarian cancer and endometrial cancer: a Mendelian randomization study.

本文引用的文献

1
Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.肠道微生物群与代谢物相结合揭示了急性心肌梗死患者不同于稳定型冠状动脉疾病患者的独特特征。
J Adv Res. 2023 Apr;46:101-112. doi: 10.1016/j.jare.2022.06.008. Epub 2022 Jun 21.
2
Qing-Xin-Jie-Yu Granule alleviates atherosclerosis by reshaping gut microbiota and metabolic homeostasis of ApoE-/- mice.清心安瘀颗粒通过重塑 ApoE-/- 小鼠肠道微生物群和代谢稳态来缓解动脉粥样硬化。
Phytomedicine. 2022 Aug;103:154220. doi: 10.1016/j.phymed.2022.154220. Epub 2022 Jun 1.
3
Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain.
肠道微生物群和血液代谢物与卵巢癌和子宫内膜癌的因果关系:一项孟德尔随机化研究。
J Ovarian Res. 2025 Mar 13;18(1):54. doi: 10.1186/s13048-025-01630-5.
4
Impact of the gut microbiome on atherosclerosis.肠道微生物群对动脉粥样硬化的影响。
mLife. 2024 Apr 1;3(2):167-175. doi: 10.1002/mlf2.12110. eCollection 2024 Jun.
5
Gut microbiome-based noninvasive diagnostic model to predict acute coronary syndromes.基于肠道微生物组的非侵入性诊断模型预测急性冠状动脉综合征。
Front Cell Infect Microbiol. 2024 Jan 11;13:1305375. doi: 10.3389/fcimb.2023.1305375. eCollection 2023.
6
Faecalibacterium prausnitzii as a potential Antiatherosclerotic microbe.普拉梭菌(Faecalibacterium prausnitzii)作为一种潜在的抗动脉粥样硬化的微生物。
Cell Commun Signal. 2024 Jan 19;22(1):54. doi: 10.1186/s12964-023-01464-y.
7
Association of the gut microbiota with coronary artery disease and myocardial infarction: A Mendelian randomization study.肠道微生物群与冠状动脉疾病和心肌梗死的关联:一项孟德尔随机化研究。
Front Genet. 2023 Apr 11;14:1158293. doi: 10.3389/fgene.2023.1158293. eCollection 2023.
年轻小鼠和老年小鼠之间的粪便微生物群转移可逆转衰老肠道、眼睛和大脑的特征。
Microbiome. 2022 Apr 29;10(1):68. doi: 10.1186/s40168-022-01243-w.
4
Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis.冠状动脉支架狭窄患者肠道微生物群失调与代谢物苯乙酰谷氨酰胺的关系
Front Cardiovasc Med. 2022 Mar 25;9:832092. doi: 10.3389/fcvm.2022.832092. eCollection 2022.
5
Evaluating supervised and unsupervised background noise correction in human gut microbiome data.评估人类肠道微生物组数据中监督和无监督背景噪声校正。
PLoS Comput Biol. 2022 Feb 7;18(2):e1009838. doi: 10.1371/journal.pcbi.1009838. eCollection 2022 Feb.
6
A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically , , : A Pilot Study.一项基于生活方式的六日沉浸式项目可减轻心血管危险因素并促使肠道微生物群发生变化,具体为[此处应补充具体微生物名称]:一项初步研究。
Nutrients. 2021 Sep 29;13(10):3459. doi: 10.3390/nu13103459.
7
Exploring the Gut Microbiota and Cardiovascular Disease.探索肠道微生物群与心血管疾病
Metabolites. 2021 Jul 29;11(8):493. doi: 10.3390/metabo11080493.
8
Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction.急性心肌梗死患者肠道微生物群失调
Front Microbiol. 2021 Jul 5;12:680101. doi: 10.3389/fmicb.2021.680101. eCollection 2021.
9
The emerging role of gut microbiota in cardiovascular diseases.肠道微生物群在心血管疾病中的新兴作用。
Indian Heart J. 2021 May-Jun;73(3):264-272. doi: 10.1016/j.ihj.2021.04.008. Epub 2021 Apr 28.
10
Gut Microbiota Dysbiosis in Human Hypertension: A Systematic Review of Observational Studies.人类高血压中的肠道微生物群失调:观察性研究的系统评价
Front Cardiovasc Med. 2021 May 14;8:650227. doi: 10.3389/fcvm.2021.650227. eCollection 2021.